Glioblastoma
|
0.020 |
PosttranslationalModification
|
disease |
BEFREE |
Immunohistochemistry revealed robust staining for phosphorylated ephrin-B and ephrin-B3 in invading glioblastoma cells.
|
16951161 |
2006 |
Glioblastoma
|
0.020 |
PosttranslationalModification
|
disease |
LHGDN |
Immunohistochemistry revealed robust staining for phosphorylated ephrin-B and ephrin-B3 in invading glioblastoma cells.
|
16951161 |
2006 |
Adult Glioblastoma
|
0.020 |
PosttranslationalModification
|
disease |
BEFREE |
Immunohistochemistry revealed robust staining for phosphorylated ephrin-B and ephrin-B3 in invading glioblastoma cells.
|
16951161 |
2006 |
Childhood Glioblastoma
|
0.020 |
PosttranslationalModification
|
disease |
BEFREE |
Immunohistochemistry revealed robust staining for phosphorylated ephrin-B and ephrin-B3 in invading glioblastoma cells.
|
16951161 |
2006 |
Glioblastoma Multiforme
|
0.020 |
PosttranslationalModification
|
disease |
BEFREE |
Immunohistochemistry revealed robust staining for phosphorylated ephrin-B and ephrin-B3 in invading glioblastoma cells.
|
16951161 |
2006 |
Neoplasms
|
0.060 |
AlteredExpression
|
group |
BEFREE |
Higher levels of EPHB6, EFNB2, and EFNB3 expression were found in low-stage tumors (stage 1, 2, and 4S) than in advanced-stage tumors (stage 3 and 4; P = 0.0013, P = 0.0048, and P = 0.027, respectively).
|
10389937 |
1999 |
Neoplasms
|
0.060 |
AlteredExpression
|
group |
BEFREE |
In this study, we showed that EFNB2 and TrkA expressions were associated with both tumor stage and age, whereas EPHB6 and EFNB3 expressions were solely associated with tumor stage, suggesting that these genes were expressed in distinct subsets of NB.
|
10984508 |
2000 |
Neoplasms
|
0.060 |
AlteredExpression
|
group |
BEFREE |
In human glioma specimens, ephrin-B3 expression and phosphorylation correlated with increasing tumor grade.
|
16951161 |
2006 |
Neoplasms
|
0.060 |
AlteredExpression
|
group |
BEFREE |
We found that Ephrin B3 was concomitantly expressed with EphA2 and Ephrin A1 with higher Ephrin B3 levels found in non-squamous than in squamous tumors, whereas EphA2 was higher expressed in well-differentiated than in low-differentiated tumors.
|
27533087 |
2016 |
Neuroblastoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Interestingly, if any one of the four genes (EPHB6, EFNB2, EFNB3, or TrkA) was expressed at high levels in NB, the patient survival was excellent (>90%).
|
10984508 |
2000 |
Central neuroblastoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Interestingly, if any one of the four genes (EPHB6, EFNB2, EFNB3, or TrkA) was expressed at high levels in NB, the patient survival was excellent (>90%).
|
10984508 |
2000 |
Childhood Neuroblastoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Interestingly, if any one of the four genes (EPHB6, EFNB2, EFNB3, or TrkA) was expressed at high levels in NB, the patient survival was excellent (>90%).
|
10984508 |
2000 |
Non-Small Cell Lung Carcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Expression of Ephrin B3 was furthermore analyzed in a cohort of NSCLC stage IA-IB cases (n=200) alongside EphA2 and Ephrin A1.
|
27533087 |
2016 |
Tumor Cell Invasion
|
0.020 |
AlteredExpression
|
phenotype |
BEFREE |
Here we show for the first time that blocking expression of the Eph ligand Ephrin B3 inhibits NSCLC cell migration and invasion.
|
27533087 |
2016 |
Glioma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Ephrin-B3 mRNA was up-regulated in migrating cells of four of four glioma cell lines (1.3- to 1.7-fold) and in invading tumor cells of eight of eight biopsy specimens (1.2- to 10.0-fold).
|
16951161 |
2006 |
Status Epilepticus
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In the present study, the expression of ephrin‑B3 in pilocarpine‑induced status epilepticus (SE) rats was investigated.
|
29512697 |
2018 |